This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. Chief Marketing Officer, AdhereHealth.
In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal sideeffects. Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology.
As cost constraints and care rationing under the transition to corporatist “value-based” care, any reduction in cost, misdiagnosis, non-targeted treatment, and unnecessary sideeffects must shift focus of care from reaction to prediction, and from Rx cycling to prevention. That said, it’s not all sunshine and roses everywhere.
However, in the long term, increased costs could be passed on to healthcare systems, insurers, and ultimately, patients. 4 Reshoring and diversification of pharmaceutical supply chains In response to potential tariffs, pharmaceuticalmanufacturers could consider shifting production closer to domestic markets to reduce exposure.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content